- Email: [email protected]
Record bookings for Flowserve
NEWS
Record bookings for Flowserve
F
lowserve Corp is reporting record bookings for both the fourth quarter and full year of 2007. Fourth quarter 2007 bookings increased 19%, to a record US$1.1 billion, including currency benefits of approximately US$75 million. This compares with bookings of US$934 million in the same period a year ago. Full year 2007 bookings also increased about 19%, to a record US$4.3 billion, including currency benefits of approximately US$200 million. This compares with bookings of US$3.6 billion for the full year of 2006. “We are very pleased with our continued strong bookings growth and are excited about the outlook for 2008 due to the robust markets we are seeing,” said Lewis Kling, Flowserve’s president and CEO. “We also believe that our strong execution abilities are enabling us to take market share from our competitors.”
For further information, visit www.flowserve.com
Dean Pump signs export agreement with Dorian Drake
M
et-Pro Corp’s Dean Pump Division has entered into an export management agreement with Dorian Drake International Inc, under which Dorian Drake will manage exports for Dean Pump in specific international markets including all of Europe, Africa, New Zealand and the Middle East, as well as a majority of Asia and parts of South America. “We are excited to have Dorian Drake as part of our team,” said Raymond De Hont, chairman and CEO of Met-Pro Corp. “As we continue to grow globally, this agreement will bring a new level of service to our existing customers and an exciting new product line to existing Dorian Drake customers. In addition, Dorian Drake’s established distribution network will provide an immediate market presence for unearthing new applications, customers and opportunities.” Indianapolis, Indiana-based Dean Pump’s major product lines include magnetic drive, 16
Pump Industry Analyst
air-cooled high temperature pumps and ANSI chemical pumps; heavy duty, high temperature process pumps; air-cooled, high temperature pumps; horizontal, vertical, and self-priming ANSI pumps; and heavy duty, industrial inline pumps. For further information, visit www.met-pro.com and www.doriandrake.com
Sulzer Pumps’ 2007 order intake exceeds SFr2 billion
S
ulzer Ltd increased its group order intake by 23.7% to SFr4 054.0 million in 2007, benefiting from the strong demand in all of its major market segments, especially in the oil and gas, hydrocarbon processing, and power generation industries. Order intake at Sulzer Pumps increased by 18.5% to a record SFr2 076.9 million. The oil and gas, the hydrocarbon processing and the power generation markets were particularly strong markets for the Sulzer Pumps division, driven by higher oil prices, increasing project sizes and high energy demand in all regions. Pump activities in the pulp and paper market remained at a high level, while the biofuel market continued to be active in Europe, but experienced a slowdown in North America because of higher raw material prices and logistical challenges. Overall, Sulzer Pumps’ growth was strong in all regions with the highest growth rates in the Americas. Sulzer’s pump order intake for 2008 is expected to remain at a high level with momentum from the oil and gas related business, as well as from the power generation industries, while the pulp and paper market is more exposed to the general economic development. For 2008, the Sulzer group expects reduced order intake growth rates. The oil and gas upstream and downstream markets are likely to remain strong, as are the power and aviation segments. The company expects some weakening in the pulp and paper and in the general industries segments. Overall, Sulzer sees slowing economic growth in the USA and Europe, whereas the other regions should continue to be strong.
For further information, visit www.sulzerpumps.com
Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843971 E-mail: [email protected] Web: www.pumpindustryanalyst.com Editor: Roisin Reidy Production Editor: Alan Stubley Subscription Information An annual subscription to Pump Industry Analyst includes 12 printed issues and online access for up to 5 users. Prices: 1049 for all European countries & Iran US$1176 for all countries except Europe and Japan ¥139 400 for Japan (Prices valid until 31 December 2008) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971/ E-mail: [email protected], or via www.pumpindustryanalyst.com. Subscriptions run for 12 months, from the date payment is received. Periodicals postage is paid at Rahway, NJ 07065, USA. Postmaster send all USA address corrections to: Pump Industry Analyst, 365 Blair Road, Avenel, NJ 07001, USA Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: [email protected]. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www. elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and e-mail addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Printed by Mayfield Press (Oxford) LImited 02167
February 2008
Record bookings for Flowserve
F
lowserve Corp is reporting record bookings for both the fourth quarter and full year of 2007. Fourth quarter 2007 bookings increased 19%, to a record US$1.1 billion, including currency benefits of approximately US$75 million. This compares with bookings of US$934 million in the same period a year ago. Full year 2007 bookings also increased about 19%, to a record US$4.3 billion, including currency benefits of approximately US$200 million. This compares with bookings of US$3.6 billion for the full year of 2006. “We are very pleased with our continued strong bookings growth and are excited about the outlook for 2008 due to the robust markets we are seeing,” said Lewis Kling, Flowserve’s president and CEO. “We also believe that our strong execution abilities are enabling us to take market share from our competitors.”
For further information, visit www.flowserve.com
Dean Pump signs export agreement with Dorian Drake
M
et-Pro Corp’s Dean Pump Division has entered into an export management agreement with Dorian Drake International Inc, under which Dorian Drake will manage exports for Dean Pump in specific international markets including all of Europe, Africa, New Zealand and the Middle East, as well as a majority of Asia and parts of South America. “We are excited to have Dorian Drake as part of our team,” said Raymond De Hont, chairman and CEO of Met-Pro Corp. “As we continue to grow globally, this agreement will bring a new level of service to our existing customers and an exciting new product line to existing Dorian Drake customers. In addition, Dorian Drake’s established distribution network will provide an immediate market presence for unearthing new applications, customers and opportunities.” Indianapolis, Indiana-based Dean Pump’s major product lines include magnetic drive, 16
Pump Industry Analyst
air-cooled high temperature pumps and ANSI chemical pumps; heavy duty, high temperature process pumps; air-cooled, high temperature pumps; horizontal, vertical, and self-priming ANSI pumps; and heavy duty, industrial inline pumps. For further information, visit www.met-pro.com and www.doriandrake.com
Sulzer Pumps’ 2007 order intake exceeds SFr2 billion
S
ulzer Ltd increased its group order intake by 23.7% to SFr4 054.0 million in 2007, benefiting from the strong demand in all of its major market segments, especially in the oil and gas, hydrocarbon processing, and power generation industries. Order intake at Sulzer Pumps increased by 18.5% to a record SFr2 076.9 million. The oil and gas, the hydrocarbon processing and the power generation markets were particularly strong markets for the Sulzer Pumps division, driven by higher oil prices, increasing project sizes and high energy demand in all regions. Pump activities in the pulp and paper market remained at a high level, while the biofuel market continued to be active in Europe, but experienced a slowdown in North America because of higher raw material prices and logistical challenges. Overall, Sulzer Pumps’ growth was strong in all regions with the highest growth rates in the Americas. Sulzer’s pump order intake for 2008 is expected to remain at a high level with momentum from the oil and gas related business, as well as from the power generation industries, while the pulp and paper market is more exposed to the general economic development. For 2008, the Sulzer group expects reduced order intake growth rates. The oil and gas upstream and downstream markets are likely to remain strong, as are the power and aviation segments. The company expects some weakening in the pulp and paper and in the general industries segments. Overall, Sulzer sees slowing economic growth in the USA and Europe, whereas the other regions should continue to be strong.
For further information, visit www.sulzerpumps.com
Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843971 E-mail: [email protected] Web: www.pumpindustryanalyst.com Editor: Roisin Reidy Production Editor: Alan Stubley Subscription Information An annual subscription to Pump Industry Analyst includes 12 printed issues and online access for up to 5 users. Prices: 1049 for all European countries & Iran US$1176 for all countries except Europe and Japan ¥139 400 for Japan (Prices valid until 31 December 2008) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971/ E-mail: [email protected], or via www.pumpindustryanalyst.com. Subscriptions run for 12 months, from the date payment is received. Periodicals postage is paid at Rahway, NJ 07065, USA. Postmaster send all USA address corrections to: Pump Industry Analyst, 365 Blair Road, Avenel, NJ 07001, USA Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: [email protected]. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www. elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and e-mail addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Printed by Mayfield Press (Oxford) LImited 02167
February 2008